KPJ Healthcare Partners with Pine Labs to offer Patients Instalment Payment Plans

KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–#BNPL–KPJ Healthcare Berhad (“KPJ Healthcare” or the “Company”) has entered into a collaboration with Pine Labs, a leading merchant commerce omnichannel platform, to offer flexible payment options for its patients. This also marks the first of its kind service to be offered at hospitals across Malaysia. Through the collaboration, payments for KPJ … [Read more…]

Bioceres Crop Solutions Reports Fiscal First Quarter 2023 Financial and Operational Results

Revenues increased 71% compared to 1Q22 pro forma numbers 1Q23 Adjusted EBITDA nearly doubled YoY, reaching $73 million on an LTM basis after excluding HB4 pre-launch costs Announced agreement with Syngenta Seedcare supporting inoculant growth internationally ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to … [Read more…]

SQZ Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio Updates

Published Comprehensive Preclinical Research on SQZ® AAC Platform in Frontiers in Immunology Continued Investigational New Drug-Enabling Activities for SQZ® TAC Platform; Submission Expected in First Half of 2023 with Clinical Batches Intended to be Manufactured on the Company’s Point-of-Care System Anticipate Interim Clinical Data for HPV16+ Solid Tumors by the End of 2022 WATERTOWN, Mass.–(BUSINESS … [Read more…]

Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance

TEANECK, N.J.–(BUSINESS WIRE)–Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2022, and reiterated its financial guidance for Net sales and Adjusted EBITDA and revised its guidance for Net income, Diluted EPS, Adjusted net income, Adjusted diluted EPS and Adjusted effective tax rate … [Read more…]

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results

Company to Conduct In-Use Study to Address FDA Latest Information Request Cash Runway Into Q4 2024 MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and released financial results for the quarter ended September 30, 2022. Clinical Developments … [Read more…]

Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #earnings–Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing … [Read more…]

MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Conducted an oral presentation covering the novel THIO platform at the XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids Presented the design of its ongoing Phase 2 THIO-101 trial at ESMO 2022 Presented results of a study of THIO in hepatocellular carcinoma in vitro and in vivo models at the Triple Meeting (EORTC-NCI-AACR) … [Read more…]

KORU Medical Systems Announces 2022 Third Quarter Financial Results

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today reported financial results for the third quarter ended September 30, 2022. Highlights: Year-over-year net … [Read more…]

Cue Health Reports Third Quarter 2022 Results

SAN DIEGO–(BUSINESS WIRE)–Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter of 2022. Recent Highlights Revenue of $69.6 million in the third quarter of 2022, exceeding guidance Flu A/B molecular test de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance for … [Read more…]

Atara Biotherapeutics to Participate at the Stifel Healthcare Conference

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that AJ Joshi, MD, Chief Medical Officer, and Utpal Koppikar, Chief Financial Officer, will participate in a fireside chat at … [Read more…]